Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine

Abstract

The neurobiological basis of panic disorder has not been clearly established, although a role for serotonin (5-HT) has been postulated. It is clear that drugs which increase 5-HT neurotransmission are effective in treating the condition but how they do so remains a point of debate. The aim of this study was to determine if lowering brain serotonin activity using the technique of tryptophan depletion provoked a short-term relapse of panic symptoms in patients with panic disorder who had responded to drug treatment. Fourteen patients with panic disorder who had responded to treatment with the selective serotonin reuptake inhibitor (SSRI) paroxetine received a tryptophan-free amino acid drink on one occasion and a control drink on the other in a double-blind crossover design. In addition, they received an infusion of flumazenil (used as a pharmacological challenge) and placebo on each day. The tryptophan depleted drink produced an 87% reduction in plasma tryptophan concentration. Flumazenil produced a panic attack (defined by changes in the panic inventory) in seven out of 14 patients when tryptophan depleted and one out of 14 on the control day (p < 0.02). Three patients also experienced temporary depressive symptoms when tryptophan depleted, with no mood changes being seen on the control days. We conclude that rapid lowering of brain serotonin function can allow the precipitation of panic symptoms in response to flumazenil in panic disorder patients who have responded to treatment with an SSRI. This implies that in panic disorder increased 5-HT availability is important in maintaining the response to SSRIs.

Keywords

5HT flumazenil panic disorder SSRIs tryptopha depletion

Get full access to this article

View all access options for this article.

References

Aberg-Wisted A , Hasselmark L , Stain-Malmgren R (1998) Serotonergic ‘vulnerability’ in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopramresponders. Acta Psychiatr Scand 97: 374–380

Barr L C , Goodman W K , McDougle C J , Delgado P L , Heninger G R , Charney D S , Price L H (1994) Tryptophan depletion in patients with obsessive compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 309–317

Beck A T , Ward C H , Mendelson M (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561–567

Bell C J , Nutt D J (1998) Serotonin and panic. Br J Psychiatry 172: 465–471

Bell C , Abrams J , Nutt D J (2001) Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 178: 399–405

Bocola V , Trecco M D , Fabbrini G , Paladini C , Sollecito A , Martucci N (1998) Antipanic effect of fluoxetine measured by CO2 challenge test. Biol Psychiatry 43: 612–615

Bradwejn J , Koszycki D (1994) Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151: 261–263

Carpenter L L , Anderson G M , Pelton G H , Gudin J A , Kirwin P D S , Price L H , Heninger G R , McDougle C J (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19: 26–35

Clark D M , Hemsley D R (1982) The effects of hyperventilation: individual variability and its relation to personality. J Behav Ther Exp Psychiatry 13: 41–47

10.

Coupland N J , Lillywhite A , Bell C J , Potokar J P , Nutt D J (1997) A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder. Biol Psychiatry 41: 988–990

11.

Coupland N J , Bell C J , Potokar J P , Dorkins E , Nutt D J (2000) Flumazenil challenge in social phobia. Depression Anxiety 11: 27–30

12.

Deakin J F W , Graeff F G (1991) 5HT and mechanisms of defence. J Psychopharmacol 5: 305–315

13.

Delgado P L , Charney D S , Price L H , Aghajanian G K , Landis H , Heninger G R (1990) Serotonin function and the mechanism of antidepressant action: reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47: 411–418

14.

Delgado P L , Miller H L , Salomon R M , Licinio J , Krystal J H , Moreno F A , Heninger G R , Charney D S (1999) Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 46: 212–220

15.

Goddard A W , Shlomskas D E , Walton K E , Augeri F M , Charney D S , Heninger G R , Goodman W K , Price L H (1994) Effects of tryptophan depletion in panic disorder. Biol Psychiatry 36: 775–777

16.

Goddard A W , Charney D S , Germine M , Woods S W , Heninger G R , Krystal J H , Goodman W K , Price L H (1995) Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry 38: 74–85

17.

Hallem D J , Kennett G A , Curzon G (1990) Hippocampal 5HT synthesis is greater in female rats than in males and more decreased by the 5HT1a agonist 8-OH-DPAT. J Neural Transm 79: 93–101

18.

Klaassen T , Klumperbeek J , Deutz N E P , van Praag H M , Griez E (1998) Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 77: 167–174

19.

Mcbride P A , Tierney H , De Meo M , Chen J S , Mann J J (1990) Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27: 1143–1155

20.

Miller H E J , Deakin J F W , Anderson I (2000) Effect of acute tryptophan depletion on CO2 induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 176: 182–188

21.

Moja E A , Cipollo P , Castoldi D , Tofanetti O (1989) Dose response increase in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci 44: 971–976

22.

Nutt D J , Cowen P J (1987) Diazepam alters brain 5HT function in man: implications for the acute and chronic effects of benzodiazepines. Psychol Med 17: 601-601

23.

Nutt D J , Glue P , Lawson C , Wilson S (1990) Flumazenil provocation of panic attacks. Arch Gen Psychiatry 47: 917–925

24.

Price L H , Malison R T , McDougle C J , McCance-Katz E F , Owen K R , Heninger G R (1997) Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology 17: 342–350

25.

Reilly J G , McTavish S F B , Young A H (1997) Rapid deplation of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol 11: 381–392

26.

Roth W T , Margraf J , Ehlers A , Taylor C B , Maddock R J , Davies S (1992) Stress test reactivity in panic disorder. Arch Gen Psychiatry 49: 301–310

27.

Savic I , Widen l , Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337: 133–137

28.

Schruers K , Klaassen T , Pols H , Overbeek T , Deutz N E P , Griez E (2000) Effects of tryptophan depletion on carbondioxide provoked panic in panic disorder patients. Psychiatry Res 93: 179–187

29.

Sheehan D V , Lecrubier Y , Harnett Sheenhan K , Janavs J , Weiller E , Keskiner A , Schinka J , Knapp E , Sheehan M F , Dunbar G C (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12: 232–241

30.

Smeraldi E , Diaferia G , Erzegovesi S , Lucca A , Bellodi L , Moja E A (1996) Tryptophan depletion in obsessive compulsive patients. Biol Psychiatry 40: 398–402

31.

Smith K A , Fairburn C G , Cowen P J (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349: 915–919

32.

Spielberger C D , Gorsuch R L , Lushese R E (1979) Manual for the State-Trait Inventory. Consulting Psychologists Press, Palo Alto, CA

33.

Weissman M M , Leaf P J , Holzer C E (1985) Epidemiology of anxiety disorders. Psychopharmacol Bull 22: 543–545

34.

Williams W A , Shoaf S E , Hommer D , Rawlings R , Linnoila M (1999) Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 72: 1641–1647

35.

Young S N , Smith S E , Phil R O , Ervin F R (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87: 173–177

36.

Young S N , Ervin F R , Pihl R O , Finn P (1989) Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 98: 508–511